Skip to main content

Table 3 Results of cost-effectiveness analysis

From: Cost-effectiveness analysis of long-course oxaliplatin and bolus of fluorouracil based preoperative chemoradiotherapy vs. 5x5Gy radiation plus FOLFOX4 for locally advanced resectable rectal cancer

Parameter

SCRT

LCCRT

Cost in US$

 Costs for the DFS state

14490

10794

 Costs for the PD state

67447

27346

 Total costs in US$

78937

38140

 Incremental costs

40797

Utilities

 Effectiveness (QALMs)

  

 Effectiveness for the DFS state

21.70

19.65

 Effectiveness for the PD state

8.22

3.33

 Total effectiveness

29.92

22.99

 Incremental effectiveness

6.93

  1. Abbreviations: SCRT Short-course radiotherapy, LCCRT Long-course chemoradiotherapy, PD Progressive disease, DFS Disease-free survival, QALM Quality-adjusted life month